Back
INmune Bio Vs. Dave Industry Stock Comparison
Sell
45
INMB
INmune Bio
Last Price:
$5.30
Seasonality Move:
-17.41%
Buy
79
DAVE
Dave
Last Price:
$89.93
Seasonality Move:
87.09%
Sell
45
INmune Bio (INMB)
is a Sell
Is INmune Bio a Buy, Sell or Hold?
-
The current INmune Bio [INMB] share price is $5.30. The Score for INMB is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
INMB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INMB Stock Price Chart
What is INmune Bio's stock price today?
-
The INmune Bio share price today is $5.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and INMB is experiencing slight buying pressure.
DAVE Stock Price Chart
INMB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 58.42 | Buy |
Chaikin Money Flow: | 158850 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.59 - 5.19) | Buy |
Bollinger Bands (100): | (4.79 - 6.29) | Sell |
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.46 | Buy |
Relative Strength Index (14 RSI): | 52.27 | Buy |
Chaikin Money Flow: | 230735 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86 - 96.94) | Sell |
Bollinger Bands (100): | (33.53 - 81.33) | Buy |
INMB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.75 | Buy |
20-day SMA: | 4.84 | Buy |
50-day SMA: | 5.22 | Buy |
200-day SMA: | 7.54 | Sell |
8-day EMA: | 4.85 | Buy |
20-day EMA: | 4.86 | Buy |
50-day EMA: | 5.13 | Buy |
200-day EMA: | 6.9 | Sell |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 92.67 | Sell |
20-day SMA: | 91.33 | Sell |
50-day SMA: | 75.49 | Buy |
200-day SMA: | 48.04 | Buy |
8-day EMA: | 91.08 | Sell |
20-day EMA: | 89.83 | Buy |
50-day EMA: | 78.42 | Buy |
200-day EMA: | 51.17 | Buy |
INmune Bio Earnings Growth & INMB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.18 per share.
Dave Earnings Growth & DAVE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.65 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.78 per share, and an increase next year of $1.12 per share.
INmune Bio Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dave Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |